Department of Clinical Neurosciences
Dr. Pamela Barton was a visionary in the field of Chronic Pain. In 1997, as co-founder of the nation's largest multi-disciplinary Chronic Pain Centre in Calgary, AB, she brought light to the sometimes bleak outlook on the management of pain.
She understood the value of collaboration between physicians of varying backgrounds and the entire interdisciplinary team in treating those suffering from chronic non-malignant pain. She was awarded substantial Alberta Heritage Foundation for Medical Research and CIHR grants looking at the utilization of resources for pain management and assessing the burden of chronic pain.
Being an expert in the management of complex musculoskeletal pain, Pam was devoted to educating herself, her colleagues and her patients about novel methods in treating and coping with pain. The AHS Chronic Pain Centre is now her legacy.
In recognition of her outstanding contributions to advancing patient care and clinical education, the Dr. Pamela Barton Memorial Fund is being established within the Cumming School of Medicine.
Donations can be made easily and securely through this link: https://netcommunity.ucalgary.ca/pambarton
Thank you so much for your consideration to support the Dr. Pamela Barton Memorial Fund, which will ensure Dr. Barton’s legacy will continue to inspire others for years to come.
Dr. Chester Ho, Section Chief of Physical Medicine and Rehabilitation, speaks in support of Accessible Housing's Fourth Dimension group home on June 16.
Minister of Human Services, Irfan Sabir, announced a $4-million investment from the Province of Alberta, which will fund a brand new facility with 45 barrier-free homes for residents. Construction is expected to begin this summer on the project—home to adults with physical mobility barriers such as spinal cord injuries, Multiple Sclerosis and Cerebral Palsy.
For more information, visit: http://accessiblehousing.ca
Full Time AARP Neuromuscular Neurologist
The Division of Neurology at the University of Calgary and Alberta Health Services is inviting applications for a Neuromuscular Neurologist. Qualifications include an MD, a specialist certificate in Neurology from the Royal College of Physicians and Surgeons of Canada or equivalent and eligibility for licensure in the Province of Alberta.
The candidate will be fellowship trained in neuromuscular disease and have a demonstrated interest and ability to support and develop clinical trials in neuromuscular disease. We are seeking an individual with proven clinical excellence, a record of working well within a team, and ability to participate fully in the City-Wide call schedule. Must read, write and speak English.
Please click here for details.
Division of Neurology: General Neurologists
General Neurology Locums: Outpatient and inpatient 9-12 month general neurology locum positions are also available beginning in April 2016.
Please click here for details.
Locum: Epilepsy Neurologist
The Calgary Comprehensive Epilepsy Programme is seeking a full time locum Neurologist for one year who is certified in EEG by the CSCN, and has formal training in the management of patients with complex epilepsies seen at a tertiary care centre, including ICU and continuous EEG monitoring, pre-surgical evaluation, proficiency and experience with various modalities of intracranial EEG planning and interpretation, ECoG, and cortical stimulation for function mapping.
Please click here for details.
QuICR is a province-wide stroke program that aims to improve stroke outcomes through rapid clinical and neuromuscular imaging evaluation combined with fast treatment.
“LOOKING BACK ON IT, I THINK WE WERE PRETTY AMBITIOUS!” recalls Dr. Robert Lee.
It was the Fall of 1979 and neurologist Dr. Lee and neurosurgeon Dr. Frank LeBlanc had been scheming with their colleagues about pooling their resources and creating something great for the people of Calgary...
Please join with the Department of Clinical Neurosciences as we celebrate not only those who envisioned our department 35 years ago, but all those who are building the future of neuroscience in Calgary,
Click here to read more and listen to former leaders of our department as they share their stories.
Former department leaders share their stories:
Dr. Oury Monchi is seeking volunteers (with and without Parkinson's Disease) for a study. Click here to find out if you can help.
Dr. Wiebe elected President of International League Against Epilepsy
Dr. Samuel Wiebe, Director of the Adult Epilepsy Program, has been elected to the role of President of the ILAE for a term to run from 2017 to 2021.
The organization, which has representation in over 110 countries, is focussed on disseminating knowledge, promoting research, education and training, and improving services and care for patients.
Dr. Wiebe said it was an honour to work with members on the group's priority areas and he looked forward to contributing based on his "clinical work in the trenches of epilepsy care."
"The ILAE maintains strong partnerships with the World Health Organization – a rare privilege among professional organizations," Dr. Wiebe noted.
Added Dr. Nathalie Jetté: "This is a very prestigious honour — Dr. Wiebe received a large proportion of the votes. We wish him all the best in this new and exciting endeavour!"
Dr. Vince Gabriel named to Board of American Burn Association
Congratulations to Dr. Vince Gabriel for being named to the American Burn Association’s Board of Trustees during the 48th Annual Meeting of the American Burn Association in Las Vegas, NV, in May 2016.
"This is testimony to Vince’s outstanding work in burn rehabilitation," said Dr. Chester Ho, Section Head for Physical Medicine and Rehabilitation.
"Please join me in congratulating Vince for this prestigious honour!"
ESCAPE Team wins President’s Excellence Award
AHS President and CEO Verna Yiu announced June 1 that the ESCAPE Team has been awarded the President’s Excellence Award for Outstanding Achievements in Research.
"This team demonstrated that an endovascular treatment (ET) can dramatically improve patient outcomes after an acute ischemic stroke," Dr. Yiu said. "Positive patient outcomes increased from 30 per cent to 55 per cent when applying ET. As well, mortality rates were reduced from 2 in 10 patients to 1 in 10 patients – a 50 per cent reduction."
Congrats to the entire team!